Narrowing Solutions for Cancer Model Adaptation Using Clinical Trial Data
Author Information
Author(s): Stamatakos Georgios S., Georgiadi Eleni C., Graf Norbert, Kolokotroni Eleni A., Dionysiou Dimitra D.
Primary Institution: National Technical University of Athens
Hypothesis
Can clinical trial data effectively narrow the possible solutions for adapting a multiscale cancer model?
Conclusion
The study successfully demonstrates that using clinical data can significantly improve the fit of a cancer model to real-world cases.
Supporting Evidence
- The model achieved an excellent fit to clinical data in terms of tumor volume reduction.
- Key parameters affecting tumor response were identified through sensitivity analysis.
- The study highlights the importance of oxygen and nutrient availability in tumor treatment response.
Takeaway
This study shows that by using real patient data, scientists can make better models to understand how tumors respond to treatment.
Methodology
The study used a multiscale cancer model to simulate tumor response to chemotherapy, specifically nephroblastoma, and adapted the model based on clinical trial data.
Potential Biases
Potential biases may arise from the selection of clinical data and the assumptions made in the model.
Limitations
The model's predictions are based on available clinical data, which may not capture all tumor characteristics.
Participant Demographics
The study focused on nephroblastoma cases from the SIOP 2001/GPOH clinical trial.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website